Latest Advances

  • Condition: Chronic Chagasic Cardiomyopathy
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Nitrofurans and Trypanocidal Drugs
  • Number of Patients: 2931
  • Published —
In this study, researchers evaluated the outcomes of nitrofurans and trypanocidal drugs for the treatment of chronic chagasic cardiomyopathy and late-stage, symptomatic Chagas disease.
  • Condition: Adults with Chronic Chagas Disease
  • Journal: PLoS neglected tropical diseases
  • Treatment Used: Fixed versus Adjusted-dose Benznidazole
  • Number of Patients: 655
  • Published —
The study researched the outcomes of fixed versus adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy.
  • Condition: Ventricular Tachycardia Ablation
  • Journal: Journal of the American Heart Association
  • Treatment Used: Laparoscopic-Guided Epicardial Access
  • Number of Patients: 11
  • Published —
This study examined the possibility and complication rates for ventricular tachycardia (rapid heartbeat) ablation performed with laparoscopic-guided epicardial access.
  • Condition: Chronic Trypanosoma cruzi Infection
  • Journal: Antimicrobial agents and chemotherapy
  • Treatment Used: Intermittent Benznidazole
  • Number of Patients: 17
  • Published —
This study tested the safety and efficacy of using intermittent benznidazole to treat patients with chronic Trypanosoma cruzi infection.
  • Condition: Chagas Cardiomyopathy
  • Journal: NULL
  • Treatment Used: Heart Transplantation
  • Number of Patients: 38
  • Published —
This study tested the safety and efficacy of using heart transplantation to treat patients with Chagas cardiomyopathy.
  • Condition: Distinct Phenotypes in Severe COVID-19
  • Journal: Respiratory physiology & neurobiology
  • Treatment Used: Personalized Respiratory Management
  • Number of Patients: 0
  • Published —
This article discusses distinct phenotypes requiring personalized respiratory management strategies in patients with severe COVID-19.
  • Condition: Chagas Heart Disease
  • Journal: The American journal of cardiology
  • Treatment Used: Physical Exercise Training
  • Number of Patients: 30
  • Published —
The study researched the outcomes of physical exercise training in patients with Chagas heart disease.
  • Condition: AIDS-Associated Kaposi Sarcoma
  • Journal: Lancet (London, England)
  • Treatment Used: Paclitaxel, Bleomycin and Cincristine, or Oral Etoposide plus Antiretroviral Therapy
  • Number of Patients: 334
  • Published —
This study investigated possible treatment for patients with advanced AIDS-associated Kaposi sarcoma.
  • Condition: Hepatitis C
  • Journal: Bulletin of the World Health Organization
  • Treatment Used: Generic versus Brand Name Medications
  • Number of Patients: 57433
  • Published —
In this study, researchers compared the effectiveness of generic versus brand name medications to treat hepatitis C.
  • Condition: Chagas Disease
  • Journal: Revista da Associacao Medica Brasileira (1992)
  • Treatment Used: Cardiac Re-Synchronization Therapy (CRT)
  • Number of Patients: 54
  • Published —
This study evaluated the prognosis after cardiac re-synchronization therapy (CRT) of a population in which Chagas disease (parasitic infection; DC) is an endemic cause of heart failure (HF).
  • Condition: Chagas Heart Disease
  • Journal: JACC. Clinical electrophysiology
  • Treatment Used: Implantable Cardioverter-Defibrillator Therapy
  • Number of Patients: 1041
  • Published —
The study researched using an implantable cardioverter-defibrillator (a small machine inside of the chest to shock the heart in a cardiac event) for chagas heart disease.
  • Condition: Chagas Disease (CD)
  • Journal: Journal of cardiovascular electrophysiology
  • Treatment Used: Implantable Cardioverter-Defibrillator (ICD)
  • Number of Patients: 117
  • Published —
This study evaluated the safety and effectiveness of an implantable cardioverter-defibrillator (ICD) for the treatment of patients with Chagas disease (CD).
Showing 1-12 of 34